0001209191-18-028611.txt : 20180508 0001209191-18-028611.hdr.sgml : 20180508 20180508165255 ACCESSION NUMBER: 0001209191-18-028611 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180507 FILED AS OF DATE: 20180508 DATE AS OF CHANGE: 20180508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARSHALL B LYNNE CENTRAL INDEX KEY: 0001073385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 18815436 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY STREET 2: SUITE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 760-603-2732 MAIL ADDRESS: STREET 1: 2855 GAZELLE CT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-07 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001073385 PARSHALL B LYNNE C/O AKCEA THERAPEUTICS, INC. 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 1 0 0 0 Stock Option (right to buy) 21.67 2018-05-07 4 A 0 53000 0.00 A 2028-05-06 Common Stock 53000 53000 D The shares vest as follows: 1/4th of the shares vest one year after May 7, 2018; 1/48th of the shares vest monthly thereafter over the next three years. /s/ Paula Soteropoulos, Attorney-in-Fact 2018-05-08